Abstract
BackgroundEltrombopag is a thrombopoietin receptor agonist (TRA). The drug has been approved for the treatment of chronic immune thrombocytopenia (ITP). The platelet (PLT) count response is usually maintained as long...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have